BCIM
IONS icon

British Columbia Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

British Columbia Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,768
Closed -$979K – 846
2021
Q1 		$979K Sell
21,768
-651
-3% -$36.3K 0.01% 791
2020
Q4 		$1.27M Sell
22,419
-535
-2% -$26.7K 0.01% 756
2020
Q3 		$1.09M Buy
22,954
+1,541
+7% +$85.6K 0.01% 734
2020
Q2 		$1.26M Buy
21,413
+6,795
+46% +$378K 0.01% 672
2020
Q1 		$691K Sell
14,618
-16,834
-54% -$938K 0.01% 656
2019
Q4 		$1.9M Buy
31,452
+13,212
+72% +$787K 0.01% 688
2019
Q3 		$1.09M Sell
18,240
-7,212
-28% -$470K 0.01% 690
2019
Q2 		$1.64M Buy
+25,452
New +$1.8M 0.01% 704
2016
Q3 		– Sell
-23,515
Closed -$548K – 680
2016
Q2 		$548K Sell
23,515
-25,112
-52% -$810K ﹤0.01% 676
2016
Q1 		$1.97M Sell
48,627
-57,254
-54% -$2.33M 0.02% 609
2015
Q4 		$6.56M Buy
105,881
+77,556
+274% +$4.18M 0.06% 352
2015
Q3 		$1.15M Sell
28,325
-8,320
-23% -$431K 0.01% 622
2015
Q2 		$2.11M Buy
36,645
+23,335
+175% +$1.48M 0.02% 562
2015
Q1 		$847K Buy
+13,310
New +$903K 0.01% 657

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

British Columbia Investment Management's IONS Position: Q2 2021 in Review

British Columbia Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 21,768 shares — an estimated $979K sold.

British Columbia Investment Management first reported a position in IONS in Q1 2015 and held it in 14 quarters. The position peaked at $6.56M in Q4 2015. 338 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • British Columbia Investment Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • British Columbia Investment Management sold 21,768 Ionis Pharmaceuticals shares in Q2 2021, an estimated $979K.
  • British Columbia Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 14 quarters.
  • British Columbia Investment Management's Ionis Pharmaceuticals position peaked at $6.56M in Q4 2015.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on British Columbia Investment Management's 13F filing for Q2 2021, filed 9 Aug 2021.